Onconic Therapeutics Inc.

Quick facts

Phase 2 pipeline

• JP-1366
• JPI-547

Phase 1 pipeline

• coadministration of JP-1366 and naproxen
• JLP-2302
• JP-1366 and apixaban
• JP-1366 and aspirin
• JP-1366 and atorvastatin
• JP-1366 and clopidogrel

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Onconic Therapeutics Inc. portfolio CI brief
• Onconic Therapeutics Inc. pipeline updates RSS